gadolinium has been researched along with Skin Diseases in 89 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 80 (89.89) | 29.6817 |
2010's | 7 (7.87) | 24.3611 |
2020's | 2 (2.25) | 2.80 |
Authors | Studies |
---|---|
Diaz-Martinez, AJ; Pagan, AD; Rodriguez-Baisi, KE; Sánchez, NP; Santaliz-Ruiz Iv, LE; Villa, J | 1 |
Clement, O; Dekkers, IA; Gianolio, E; Karst, U; Mallio, CA; Nederveen, AJ; Parillo, M; Quattrocchi, CC; Radbruch, A; Ramalho, J; Ramalho, M; Rovira, À; Stroomberg, G; Van der Molen, AJ | 1 |
Burke, LM; Ramalho, J; Ramalho, M; Semelka, RC | 1 |
Prybylski, JP; Ramalho, M; Semelka, RC | 1 |
Creamer, D; Fleming, H; McNeill, G; Tasker, F; Walsh, S | 1 |
Davenport, MS | 1 |
Aarabi, M; Akbarian, F; Boroumand, B; Memon, KK; Shafiee, MA | 1 |
Bachman, M; Bloom, RD; Carlow, D; Drott, HR; Milone, M; Murashima, M; Shaw, LM; Tsai, DE; Yang, SL | 1 |
Bennett, LK; Garrett, AL | 1 |
Bhave, G; Chang, SS; Lewis, JB | 1 |
Kay, J; Todd, DJ | 1 |
Thomsen, HS | 2 |
Morcos, SK; Thomsen, HS | 1 |
Baumgarten, M; Gehr, T; Mirovski, M | 1 |
Shellock, FG; Spinazzi, A | 1 |
Colletti, PM | 1 |
Becker, S; Kribben, A; Witzke, O | 1 |
Brooks, S; Chwalek, J; Deng, A; Gaspari, A; Kao, G; Martin, DB; Petrali, J; Sina, B; Spillane, A; St Surin-Lord, S | 1 |
Amuluru, L; Hiatt, KM; High, W; Malik, B; Ranville, J; Shah, SV; Swaminathan, S | 1 |
Abraham, JL; Thakral, C | 3 |
Breitschaft, A; Stahlmann, R | 1 |
Korman, NJ; Paspulati, RM; Robinson, MR; Routhouska, SB | 1 |
Ayers, RA; Chandler, J; Cowper, SE; High, WA; Zito, G | 1 |
Finsterer, J; Stöllberger, C | 1 |
Abraham, JL; Boyd, AS; Zic, JA | 1 |
Dharnidharka, VR; Fennell, RS; Wesson, SK | 1 |
Abu-Alfa, AK; Cowper, SE; Kanal, E; Kuo, PH | 1 |
Mitka, M | 1 |
Hellman, RN | 1 |
Galaria, N; Gust, A; Hanjani, NM; Poggioli, G; Pryor, JG; Robison, J; Samie, F; Scott, GA | 1 |
Chan, LP; Goh, NS; Lee, HY; Lim, YL; Low, SC; Pang, SM | 1 |
Bongartz, G | 1 |
Brown, JJ; Lin, SP | 1 |
Partain, CL | 1 |
Pedersen, M | 1 |
Endre, ZH | 1 |
Jamboti, J | 1 |
Heymann, WR | 1 |
Perazella, MA; Rodby, RA | 1 |
Chan, BP; Goveia, M; Patel, PR | 1 |
Abul-Ezz, S; Bornhorst, JA; Horn, TD; Pellowski, D; Shah, SV; Swaminathan, S; Viswamitra, S | 1 |
Collidge, TA; Jardine, AG; Mark, PB; Morris, ST; Roditi, GH; Simpson, K; Thomson, PC; Traynor, JP | 1 |
Nagy, J; Pintér, I; Vágási, K; Wittmann, I | 1 |
Budisavljevic, MN; Maize, JC; Othersen, JB; Woolson, RF | 1 |
Greenberg, CS; Parsons, AC; Sane, DC; Sangüeza, OP; Sheehan, DJ; Yosipovitch, G | 1 |
Chibnik, LB; Kagan, A; Kay, J; Todd, DJ | 1 |
Bucala, R; Cowper, SE; Kuo, PH | 1 |
Aime, S; Canavese, C; Stratta, P | 2 |
Baramidze, G; Lauenstein, TC; Martin, DR; Morreira, R; Salman, K; Singh-Parker, S; Tata, S; Tudorascu, D | 1 |
Ersoy, H; Rybicki, FJ | 1 |
Barkhausen, J; Daul, A; Hillen, U; Kribben, A; Witzke, O | 1 |
Abraham, JL; Helm, TN; Kalb, RE; Kanal, E; Sperry, H; Thakral, C | 1 |
Weinreb, JC | 2 |
Cowper, SE | 1 |
Kuo, PH | 1 |
Bucala, R | 1 |
Girardi, M | 1 |
Abu-Alfa, A | 1 |
Caccetta, T; Chan, JJ | 1 |
Shenoy, C | 1 |
Hiremagalur, B; Kurtkoti, J; Snow, T | 1 |
Bos, JD; Keur, I; Scheepstra, CG; van der Meij, N; van Lienden, KP | 1 |
Dhungel, A; Lattupalli, R; Topf, J | 1 |
Reilly, RF | 1 |
Cohan, RH; Ellis, JH; Francis, IR; Hussain, HK; Mukherji, SK; Shabana, WM; Su, LD; Swartz, RD | 1 |
Avery, LL; Bazari, H; Kay, J; Koreishi, AF | 1 |
Boehm, I | 1 |
Martin, DR | 1 |
Cowper, SE; Girardi, M; Rabach, M | 1 |
Bilecen, D; Bongartz, G; Mayr, M | 1 |
Marckmann, P; Thomsen, HS | 2 |
Abu-Alfa, A; Saab, G | 1 |
Morcos, SK | 1 |
Bellin, MF; Van Der Molen, AJ | 1 |
Chan, LP; Kei, PL | 1 |
Stenver, DI | 1 |
Broome, DR | 1 |
Perazella, MA | 1 |
Banas, B; Coras, B; Hausser, I; Hofstaedter, F; Krämer, BK; Mack, M; Reinhold, S; Schroeder, JA; Seybold, V; Vogt, T; Weingart, C | 1 |
Frenzel, T; Lengsfeld, P; Pietsch, H; Schirmer, H; Sieber, MA; Siegmund, F; Walter, J; Weinmann, HJ | 1 |
Lenkinski, RE; Rofsky, NM; Sherry, AD | 1 |
35 review(s) available for gadolinium and Skin Diseases
Article | Year |
---|---|
Gadolinium Retention and Toxicity-An Update.
Topics: Brain; Cognitive Dysfunction; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Pain; Renal Insufficiency, Chronic; Skin Diseases | 2017 |
Contrast media and cutaneous reactions. Part 1. Immediate hypersensitivity reactions to contrast media and gadolinium deposition.
Topics: Contrast Media; Gadolinium; Humans; Hypersensitivity, Immediate; Skin Diseases; Tissue Distribution | 2019 |
Dermatologic Manifestations in End-stage Renal Disease.
Topics: Calcinosis; Calciphylaxis; Gadolinium; Humans; Kidney Failure, Chronic; Nail Diseases; Nephrogenic Fibrosing Dermopathy; Pigmentation Disorders; Pruritus; Skin Diseases; Skin Diseases, Vesiculobullous; Uremia | 2015 |
Nephrogenic systemic fibrosis: is gadolinium the missing piece to the puzzle?
Topics: Acidosis; Contrast Media; Fibrosis; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Renal Dialysis; Renal Insufficiency; Risk Factors; Skin; Skin Diseases | 2008 |
Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Renal Insufficiency; Skin Diseases | 2008 |
Nephrogenic systemic fibrosis: an epidemic of gadolinium toxicity.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney; Kidney Failure, Chronic; Skin; Skin Diseases | 2008 |
Nephrogenic systemic fibrosis: more questions and some answers.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Risk Factors; Skin; Skin Diseases | 2008 |
MRI safety update 2008: part 1, MRI contrast agents and nephrogenic systemic fibrosis.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Renal Insufficiency; Skin Diseases | 2008 |
[Nephrogenic systemic fibrosis].
Topics: Acute Kidney Injury; Biopsy; Contrast Media; Gadolinium; Humans; Kidney Failure, Chronic; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Skin; Skin Diseases | 2009 |
[Nephrogenic systemic fibrosis].
Topics: Contrast Media; Fibrosis; Gadolinium; Glomerular Filtration Rate; Humans; Kidney Diseases; Skin Diseases | 2009 |
Gadolinium deposition in nephrogenic fibrosing dermopathy.
Topics: Acidosis; Aged; Blood Vessels; Bone Marrow Cells; Calcium Phosphates; Contrast Media; Cyclosporine; Electron Probe Microanalysis; Female; Fibrosis; Gadolinium; Hepatitis C, Chronic; Humans; Hypocalcemia; Kidney Failure, Chronic; Liver Failure; Magnetic Resonance Imaging; Microscopy, Electron, Scanning; Models, Biological; Phosphates; Postoperative Complications; Renal Dialysis; Skin; Skin Diseases | 2007 |
Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature.
Topics: Adult; Aged; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Failure, Chronic; Male; Skin Diseases | 2007 |
Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency?
Topics: Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Practice Patterns, Physicians'; Renal Insufficiency; Risk Assessment; Risk Factors; Skin Diseases | 2007 |
MR contrast agents: physical and pharmacologic basics.
Topics: Breast Feeding; Cardiovascular System; Contrast Media; Extravasation of Diagnostic and Therapeutic Materials; Female; Fibrosis; Gadolinium; Humans; Hypocalcemia; Kidney; Magnetic Resonance Imaging; Pediatrics; Practice Guidelines as Topic; Pregnancy; Skin Diseases | 2007 |
[Nephrogenic systemic fibrosis].
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Kidney Transplantation; Magnetic Resonance Imaging; Photopheresis; Plasmapheresis; Renal Dialysis; Skin; Skin Diseases | 2007 |
Nephrogenic systemic fibrosis: center case review.
Topics: Adolescent; Adult; Aged; Cohort Studies; Comorbidity; Contrast Media; Female; Fibrosis; Gadolinium; Humans; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Renal Insufficiency; Risk Assessment; Risk Factors; Skin Diseases | 2007 |
Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis.
Topics: Contrast Media; Dose-Response Relationship, Drug; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Renal Insufficiency; Skin Diseases | 2007 |
[Nephrogenic systemic fibrosis--a new interdisciplinary challenge].
Topics: Biopsy; Contraindications; Contrast Media; Diagnosis, Differential; Fibrosis; Gadolinium; Gadolinium DTPA; Germany; Glucocorticoids; Humans; Kidney Transplantation; Magnetic Resonance Imaging; Photopheresis; Plasmapheresis; Prednisone; Registries; Renal Insufficiency; Risk Factors; Skin; Skin Diseases | 2007 |
Nephrogenic systemic fibrosis: an overview.
Topics: Acidosis; Animals; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney; Magnetic Resonance Imaging; Renal Insufficiency; Skin; Skin Diseases | 2008 |
Gadolinium-containing MRI contrast agents: important variations on a theme for NSF.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Renal Insufficiency; Skin; Skin Diseases; Thermodynamics | 2008 |
Circulating fibrocytes: cellular basis for NSF.
Topics: Animals; Cell Differentiation; Cell Proliferation; Connective Tissue; Contrast Media; Fibroblasts; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Renal Insufficiency; Skin; Skin Diseases | 2008 |
Nephrogenic systemic fibrosis: a dermatologist's perspective.
Topics: Contrast Media; Diagnosis, Differential; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Renal Insufficiency; Skin; Skin Diseases | 2008 |
The impact of NSF on the care of patients with kidney disease.
Topics: Acidosis; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Risk Factors; Skin; Skin Diseases | 2008 |
Gadolinium and nephrogenic systemic fibrosis: association or causation.
Topics: Contrast Media; Epidemiologic Methods; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Patient Selection; Practice Guidelines as Topic; Renal Insufficiency; Risk Assessment; Risk Factors; Severity of Illness Index; Skin Diseases | 2008 |
Nephrogenic system fibrosis: a radiologist's practical perspective.
Topics: Contrast Media; Documentation; Dose-Response Relationship, Drug; Fibrosis; Gadolinium; Humans; Informed Consent; Kidney Diseases; Magnetic Resonance Imaging; Renal Dialysis; Risk Factors; Skin Diseases | 2008 |
Clinical and histological findings in nephrogenic systemic fibrosis.
Topics: Contrast Media; Diagnosis, Differential; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Skin Diseases | 2008 |
Magnetic resonance angiography (MRA) in renally impaired patients: when and how.
Topics: Contrast Media; Decision Making; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Angiography; Skin Diseases | 2008 |
Extracellular Gd-CA: differences in prevalence of NSF.
Topics: Adverse Drug Reaction Reporting Systems; Contrast Media; Dose-Response Relationship, Drug; Fibrosis; Gadolinium; Gadolinium DTPA; Humans; Kidney Diseases; Magnetic Resonance Imaging; Prevalence; Registries; Skin Diseases | 2008 |
Nephrogenic systemic fibrosis--implications for nephrologists.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Risk Factors; Skin Diseases | 2008 |
Extracellular gadolinium contrast agents: differences in stability.
Topics: Contrast Media; Drug Stability; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Skin Diseases | 2008 |
Extracellular gadolinium-based contrast media: an overview.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Image Enhancement; Kidney Diseases; Magnetic Resonance Imaging; Osmolar Concentration; Skin Diseases; Teratogens; Viscosity | 2008 |
Pharmacovigilance: what to do if you see an adverse reaction and the consequences.
Topics: Adverse Drug Reaction Reporting Systems; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Product Surveillance, Postmarketing; Skin Diseases | 2008 |
Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Organ Specificity; Risk Factors; Skin Diseases | 2008 |
Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis.
Topics: Animals; Clinical Trials as Topic; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney; Magnetic Resonance Imaging; Renal Insufficiency; Skin; Skin Diseases; Tissue Distribution | 2008 |
Gadolinium-enhanced magnetic resonance imaging, renal failure and nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Renal Dialysis; Renal Insufficiency; Risk; Skin Diseases | 2008 |
54 other study(ies) available for gadolinium and Skin Diseases
Article | Year |
---|---|
An Unusual Case of Deep Localized Scleroderma in a Patient with Chronic Kidney Disease.
Topics: Contrast Media; Disease Progression; Female; Gadolinium; Humans; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Scleroderma, Localized; Skin Diseases | 2022 |
Skin Toxicity After Exposure to Gadolinium-Based Contrast Agents in Normal Renal Function, Using Clinical Approved Doses: Current Status of Preclinical and Clinical Studies.
Topics: Animals; Brain; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Kidney; Magnetic Resonance Imaging; Organometallic Compounds; Skin Diseases; Tissue Inhibitor of Metalloproteinase-1 | 2023 |
Influence of excess ligand on Nephrogenic Systemic Fibrosis associated with nonionic, linear gadolinium-based contrast agents.
Topics: Adverse Drug Reaction Reporting Systems; Animals; Contrast Media; Databases, Factual; Fibrosis; Gadolinium; Gadolinium DTPA; Humans; Incidence; Kinetics; Ligands; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Rats; Retrospective Studies; Skin Diseases; Thermodynamics; United States | 2019 |
Virtual Elimination of Nephrogenic Systemic Fibrosis: A Medical Success Story with a Small Asterisk.
Topics: Biopsy; Fibrosis; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Skin Diseases | 2019 |
Removal of gadolinium by peritoneal dialysis.
Topics: Contrast Media; Fibrosis; Gadolinium; Gadolinium DTPA; Humans; Kidney Failure, Chronic; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Peritoneal Dialysis; Skin Diseases | 2008 |
Is NSF only the tip of the "gadolinium toxicity" iceberg?
Topics: Contrast Media; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Skin Diseases | 2008 |
Progressive skin fibrosis.
Topics: Contrast Media; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diagnosis, Differential; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Skin; Skin Diseases | 2008 |
Nephrogenic systemic fibrosis and gadolinium: a perfect storm.
Topics: Contrast Media; Drug Approval; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Renal Insufficiency; Skin Diseases; United States; United States Food and Drug Administration | 2008 |
Nephrogenic systemic fibrosis with a spectrum of clinical and histopathological presentation: a disorder of aberrant dermal remodeling.
Topics: Adult; Calcinosis; Cell Proliferation; Disease Progression; Female; Gadolinium; Humans; Kidney Failure, Chronic; Leukocytes; Male; Medical Records; Middle Aged; Nephrogenic Fibrosing Dermopathy; Retrospective Studies; Skin; Skin Diseases | 2010 |
Metal deposition in calcific uremic arteriolopathy.
Topics: Adult; Aged; Aged, 80 and over; Aluminum; Arterial Occlusive Diseases; Arterioles; Calciphylaxis; Contrast Media; Female; Gadolinium; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Retrospective Studies; Skin; Skin Diseases | 2009 |
Gadolinium-induced nephrogenic systemic fibrosis is associated with insoluble Gd deposits in tissues: in vivo transmetallation confirmed by microanalysis.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Microscopy, Electron, Scanning; Nephrogenic Fibrosing Dermopathy; Skin; Skin Diseases; Spectrometry, X-Ray Emission | 2009 |
Alefacept therapy for nephrogenic systemic fibrosis: a case series.
Topics: Aged; Alefacept; Contrast Media; Dermatologic Agents; Female; Gadolinium; Humans; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Recombinant Fusion Proteins; Skin Diseases | 2011 |
Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis.
Topics: Acidosis; Contrast Media; Electron Probe Microanalysis; Fibrosis; Gadolinium; Humans; Iron; Lysosomes; Metals; Microscopy, Electron, Scanning; Organ Specificity; Paraffin Embedding; Pilot Projects; Renal Insufficiency; Single-Blind Method; Skin; Skin Diseases | 2007 |
Dermal and extra-dermal manifestations of gadolinium-triggered nephrogenic fibrosing dermopathy.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Skin; Skin Diseases | 2006 |
Gadolinium and nephrogenic fibrosing dermopathy in pediatric patients.
Topics: Child; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Skin; Skin Diseases | 2007 |
Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis.
Topics: Clinical Trials as Topic; Contrast Media; Evidence-Based Medicine; Fibrosis; Gadolinium; Humans; Incidence; Kidney Failure, Chronic; Magnetic Resonance Imaging; Risk Assessment; Risk Factors; Skin; Skin Diseases | 2007 |
MRI contrast agents may pose risk for patients with kidney disease.
Topics: Comorbidity; Contrast Media; Fibrosis; Gadolinium; Gadolinium DTPA; Humans; Kidney Diseases; Magnetic Resonance Imaging; Risk; Skin Diseases; Syndrome | 2007 |
Erythropoietin, gadolinium, and nephrogenic fibrosing dermopathy.
Topics: Erythropoietin; Fibrosis; Gadolinium; Humans; Recombinant Proteins; Renal Insufficiency; Skin Diseases | 2007 |
Nephrogenic fibrosing dermopathy associated with exposure to gadolinium-containing contrast agents--St. Louis, Missouri, 2002-2006.
Topics: Case-Control Studies; Comorbidity; Contrast Media; Female; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Missouri; Renal Dialysis; Risk Factors; Skin Diseases | 2007 |
Nephrogenic systemic fibrosis: a clinicopathologic study of six cases.
Topics: Adult; Aged; Contrast Media; Erythropoietin; Female; Fibrosis; Gadolinium; Humans; Male; Middle Aged; Renal Dialysis; Renal Insufficiency; Retrospective Studies; Skin Diseases; Surgical Procedures, Operative | 2007 |
On the potential causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis.
Topics: Congresses as Topic; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney; Magnetic Resonance Imaging; Periodicals as Topic; Practice Guidelines as Topic; Skin Diseases | 2007 |
Safety update on the possible causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney; Magnetic Resonance Imaging; Safety; Skin Diseases | 2007 |
Nephrogenic systemic fibrosis: is any contrast safe in renal failure?
Topics: Fibrosis; Gadolinium; Humans; Kidney Failure, Chronic; Radiopharmaceuticals; Skin; Skin Diseases | 2007 |
Strong association between the use of gadolinium-based contrast agents with nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
Topics: Fibrosis; Gadolinium; Humans; Kidney Failure, Chronic; Magnetic Resonance Imaging; Radiopharmaceuticals; Skin Diseases | 2007 |
Nephrogenic systemic fibrosis--the beginning of the end?
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Renal Dialysis; Renal Insufficiency; Skin Diseases | 2007 |
Renal failure and gadolinium: danger.
Topics: Contrast Media; Europe; Fibrosis; Gadolinium; Humans; Kidney Failure, Chronic; Skin Diseases | 2007 |
Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney disease.
Topics: Fibrosis; Gadolinium; Humans; Kidney Diseases; Radioisotopes; Radiopharmaceuticals; Skin Diseases | 2007 |
Evaluating the role of recombinant erythropoietin in nephrogenic systemic fibrosis.
Topics: Adult; Case-Control Studies; Drug Interactions; Erythropoietin; Female; Fibrosis; Gadolinium; Hematinics; Humans; Kidney Failure, Chronic; Male; Middle Aged; Radiopharmaceuticals; Recombinant Proteins; Risk Factors; Skin; Skin Diseases | 2007 |
Nephrogenic systemic fibrosis, gadolinium, and iron mobilization.
Topics: Contrast Media; Fatal Outcome; Fibrosis; Gadolinium; Humans; Iron; Renal Insufficiency; Skin Diseases | 2007 |
Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort.
Topics: Adult; Aged; Contrast Media; Female; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Renal Dialysis; Renal Insufficiency; Retrospective Studies; Skin Diseases | 2007 |
Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure.
Topics: Adult; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Failure, Chronic; Magnetic Resonance Imaging; Peritoneal Dialysis, Continuous Ambulatory; Renal Insufficiency; Retrospective Studies; Skin Diseases | 2007 |
Transglutaminases: the missing link in nephrogenic systemic fibrosis.
Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biopsy; Case-Control Studies; Contrast Media; Factor XIIIa; Female; Fibroblasts; Fibrosis; Gadolinium; Histiocytes; Humans; Male; Middle Aged; Renal Insufficiency; Skin; Skin Diseases; Syndrome; Transglutaminases | 2007 |
Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fibrosis; Follow-Up Studies; Gadolinium; Humans; Kidney Diseases; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Skin; Skin Diseases; Syndrome | 2007 |
Nephrogenic systemic fibrosis and gadolinium exposure: association and lessons for idiopathic fibrosing disorders.
Topics: Fibrosis; Gadolinium; Humans; Kidney; Kidney Diseases; Kidney Failure, Chronic; Magnetic Resonance Imaging; Radiopharmaceuticals; Skin; Skin Diseases | 2007 |
Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate.
Topics: Chelating Agents; Contraindications; Fibrosis; Gadolinium; Humans; Kidney Diseases; Kidney Failure, Chronic; Lanthanum; Skin Diseases; United States; United States Food and Drug Administration; Uremia | 2007 |
Automated scanning electron microscopy and x-ray microanalysis for in situ quantification of gadolinium deposits in skin.
Topics: Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Microscopy, Electron, Scanning; Skin; Skin Diseases; Spectrometry, X-Ray Emission | 2007 |
ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis.
Topics: Chemical and Drug Induced Liver Injury; Contrast Media; Fibrosis; Gadolinium; Humans; Renal Dialysis; Skin Diseases | 2007 |
Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury.
Topics: Contrast Media; Fibrosis; Gadolinium; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Skin; Skin Diseases; Treatment Outcome | 2008 |
Introduction to this issue on NSF.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Renal Insufficiency; Skin; Skin Diseases | 2008 |
Impact on hospital policy: Yale experience.
Topics: Connecticut; Contrast Media; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Organizational Case Studies; Radiology Department, Hospital; Renal Insufficiency; Safety Management; Skin; Skin Diseases | 2008 |
Nephrogenic systemic fibrosis associated with liver transplantation, renal failure and gadolinium.
Topics: Acute Kidney Injury; Antigens, CD34; Cholangiopancreatography, Magnetic Resonance; Contrast Media; Fibrosis; Gadolinium; Humans; Immunohistochemistry; Liver Transplantation; Male; Middle Aged; Renal Dialysis; Skin; Skin Diseases | 2008 |
Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney and liver disease.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Liver Failure; Magnetic Resonance Imaging; Renal Insufficiency; Risk Factors; Skin Diseases | 2008 |
[Nephrogenic systemic fibrosis possibly caused by gadolinium-containing contrast agent].
Topics: Adult; Contrast Media; Female; Fibrosis; Gadolinium; Humans; Renal Insufficiency; Skin Diseases | 2007 |
Nephrogenic fibrosing dermopathy.
Topics: Contrast Media; Female; Gadolinium; Graft Rejection; Humans; Kidney Failure, Chronic; Kidney Transplantation; Magnetic Resonance Imaging; Middle Aged; Skin Diseases | 2008 |
Risk for nephrogenic systemic fibrosis with gadoteridol (ProHance) in patients who are on long-term hemodialysis.
Topics: Aged; Contrast Media; Female; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Hospitals, Veterans; Humans; Kidney Diseases; Kidney Failure, Chronic; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Renal Dialysis; Risk Assessment; Skin Diseases; Texas; Time Factors | 2008 |
Nephrogenic systemic fibrosis: a report of 29 cases.
Topics: Adult; Aged; Cohort Studies; Contrast Media; Databases, Factual; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Middle Aged; Prevalence; Renal Dialysis; Renal Insufficiency; Retrospective Studies; Skin Diseases | 2008 |
Case records of the Massachusetts General Hospital. Case 6-2008. A 46-year-old woman with renal failure and stiffness of the joints and skin.
Topics: Amyloidosis; Diagnosis, Differential; Fatal Outcome; Female; Fibrosis; Gadolinium; Humans; Joint Diseases; Kidney; Kidney Failure, Chronic; Middle Aged; Myocardium; Peripheral Nervous System Diseases; Pulmonary Fibrosis; Shock, Septic; Skin; Skin Diseases | 2008 |
Nephrogenic systemic fibrosis in patients undergoing hemodialysis: comment on the article by Todd et al.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Renal Dialysis; Skin Diseases | 2008 |
MRI contrast media are used to improve visualization of abnormal structures or lesions in various parts of the body. Introduction.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Image Enhancement; Kidney Diseases; Magnetic Resonance Imaging; Skin Diseases | 2008 |
Gadolinium chelate-associated nephrogenic systemic fibrosis.
Topics: Contrast Media; Creatinine; Gadolinium; Glomerular Filtration Rate; Humans; Kidney Diseases; Scleroderma, Systemic; Singapore; Skin; Skin Diseases | 2008 |
How should nephrologists approach gadolinium-based contrast imaging in patients with kidney disease?
Topics: Contrast Media; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Kidney Diseases; Kidney Failure, Chronic; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Organometallic Compounds; Patient Selection; Renal Dialysis; Risk Assessment; Skin Diseases; Time Factors | 2008 |
Ultrastructural evidence of dermal gadolinium deposits in a patient with nephrogenic systemic fibrosis and end-stage renal disease.
Topics: Aged; Calcium; Cell Differentiation; Contrast Media; Dermis; Fibroblasts; Fibrosis; Gadolinium; Gadolinium DTPA; Humans; Iron; Kidney Failure, Chronic; Magnesium; Male; Microscopy, Electron, Transmission; Microscopy, Energy-Filtering Transmission Electron; Skin Diseases; Spectroscopy, Electron Energy-Loss | 2008 |
Gadolinium-based contrast agents and their potential role in the pathogenesis of nephrogenic systemic fibrosis: the role of excess ligand.
Topics: Animals; Contrast Media; Copper; Fibrosis; Gadolinium; Gadolinium DTPA; Kidney Diseases; Ligands; Male; Organometallic Compounds; Rats; Skin Diseases; Statistics, Nonparametric; Tissue Distribution; Zinc | 2008 |
Nephrogenic systemic fibrosis: a chemical perspective.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Molecular Structure; Renal Insufficiency; Skin Diseases; Thermodynamics | 2008 |